Search research articles
Contact Us
Filters
Showing results (591-600 of 646) with videos related to
Page
of 65
Sort By:
The Lancet. Respiratory Medicine
|
October 2, 2025
Assessment of the role of small airway dysfunction in relation to exacerbation risk in patients with well controlled asthma (ATLANTIS): an observational study
Stanley P Galant, Pauline J M Kuks, Tessa M Kole, et al.
Allergy
|
November 10, 2025
Cluster Analysis to Identify Distinct Asthma Phenotypes in the ATLANTIS Cohort
Pauline J M Kuks, Tatiana Karp, Jorine E Hartman, et al.
Respiration; International Review of Thoracic Diseases
|
January 8, 2026
Lung function impairment after mild SARS-CoV-2 infection in previously healthy individuals
Thomas Bahmer, Anne-Kathrin Ruß, Lennart Michel Reinke, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 5, 2010
Chronic obstructive pulmonary disease phenotypes: the future of COPD
MeiLan K Han, Alvar Agusti, Peter M Calverley, et al.
The New England Journal of Medicine
|
June 5, 2023
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
Surya P Bhatt, Klaus F Rabe, Nicola A Hanania, et al.
Respiratory Research
|
July 13, 2024
Midregional Proatrial Natriuretic Peptide (MRproANP) is associated with vertebral fractures and low bone density in patients with chronic obstructive pulmonary disease (COPD)
Franziska C Trudzinski, Rudolf A Jörres, Peter Alter, et al.
The Journal of Allergy and Clinical Immunology
|
April 10, 2007
Severe asthma in adults: what are the important questions?
Pascal Chanez, Sally E Wenzel, Gary P Anderson, et al.
Allergy
|
March 10, 2026
Nasal Airway Transcriptome Reflects Selected Asthma-Associated Gene Signatures in the Lower Airways
Hui Wen, Tessa Kole, Orestes A Carpaij, et al.
The Lancet. Respiratory Medicine
|
April 2, 2021
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial
Jürgen Behr, Antje Prasse, Michael Kreuter, et al.
Allergy
|
May 29, 2026
Effect of Dupilumab on Airway Inflammation in Patients With Persistent Asthma
Michael E Wechsler, Sally E Wenzel, Steve D Groshong, et al.
Page
of 65
Search research articles
Search
Showing results (591-600 of 646) with videos related to
Sort By:
Page
of 65
The Lancet. Respiratory Medicine
|
October 2, 2025
Assessment of the role of small airway dysfunction in relation to exacerbation risk in patients with well controlled asthma (ATLANTIS): an observational study
Stanley P Galant, Pauline J M Kuks, Tessa M Kole, et al.
Allergy
|
November 10, 2025
Cluster Analysis to Identify Distinct Asthma Phenotypes in the ATLANTIS Cohort
Pauline J M Kuks, Tatiana Karp, Jorine E Hartman, et al.
Respiration; International Review of Thoracic Diseases
|
January 8, 2026
Lung function impairment after mild SARS-CoV-2 infection in previously healthy individuals
Thomas Bahmer, Anne-Kathrin Ruß, Lennart Michel Reinke, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 5, 2010
Chronic obstructive pulmonary disease phenotypes: the future of COPD
MeiLan K Han, Alvar Agusti, Peter M Calverley, et al.
The New England Journal of Medicine
|
June 5, 2023
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
Surya P Bhatt, Klaus F Rabe, Nicola A Hanania, et al.
Respiratory Research
|
July 13, 2024
Midregional Proatrial Natriuretic Peptide (MRproANP) is associated with vertebral fractures and low bone density in patients with chronic obstructive pulmonary disease (COPD)
Franziska C Trudzinski, Rudolf A Jörres, Peter Alter, et al.
The Journal of Allergy and Clinical Immunology
|
April 10, 2007
Severe asthma in adults: what are the important questions?
Pascal Chanez, Sally E Wenzel, Gary P Anderson, et al.
Allergy
|
March 10, 2026
Nasal Airway Transcriptome Reflects Selected Asthma-Associated Gene Signatures in the Lower Airways
Hui Wen, Tessa Kole, Orestes A Carpaij, et al.
The Lancet. Respiratory Medicine
|
April 2, 2021
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial
Jürgen Behr, Antje Prasse, Michael Kreuter, et al.
Allergy
|
May 29, 2026
Effect of Dupilumab on Airway Inflammation in Patients With Persistent Asthma
Michael E Wechsler, Sally E Wenzel, Steve D Groshong, et al.
Page
of 65